Cancer.Net is pleased to offer its patient information on cancer research, treatment, coping, and many other topics in an audio podcast format. This gives people with cancer, and their families and friends, an additional option of how they'd like to receive oncologist-approved information from Cancer.Net.
The Cancer.Net Podcasts series has been awarded a Merit Award in the Digital Health Awards (PDF) competition, which recognizes high-quality digital health resources for consumers and health professionals. The awards are organized by the Health Information Resource Center.
A Cancer.Net Podcast is a pre-recorded audio file in which a specific cancer-related topic is addressed in order to assist people with cancer. A podcast can be listened to online (through the Internet) or downloaded to your computer free of charge. After downloading, a Cancer.Net Podcast may also be transferred to an MP3 audio player, such as an iPod. To download or listen to a Cancer.Net Podcast on your computer, you will need software capable of playing MP3 files, such as Windows Media Player or QuickTime.
You may also want to subscribe to Cancer.Net Podcasts, so that new offerings are automatically downloaded to your personal computer as soon as they are available. To subscribe, copy-and-paste the link below into software that allows podcast subscriptions, such as iTunes or Juice.
This podcast is part of a series for patients who have just been diagnosed with a specific genitourinary, or GU cancer. In this series, Dr. Charles Ryan, a medical oncologist and professor who specializes in the genitourinary tract at the UCSF Helen Diller Family Comprehensive Cancer Center, speaks with experts on specific GU cancers to shed light on what happens after an initial diagnosis.
Today’s guest is Dr. Thomas Powles, clinical professor of genitourinary oncology at Barts Cancer Institute in London. In this podcast, Dr. Ryan and Dr. Powles discuss what happens after a diagnosis of metastatic bladder cancer, including new advances in immunotherapy for bladder cancer.
This podcast is part of a series for patients who have just been diagnosed with a specific genitourinary, or GU cancer. In this series, Dr. Charles Ryan, a medical oncologist and associate professor who specializes in the genitourinary tract at the UCSF Helen Diller Family Comprehensive Cancer Center, speaks with experts on specific GU cancers to shed light on what happens after an initial diagnosis.
Today’s guest is Dr. Brian Rini, an associate professor of medicine and a staff member in the Department of Solid Tumor Oncology at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. Dr. Ryan and Dr. Rini discuss the decisions that doctors make when a patient is diagnosed with kidney cancer, including some of the factors that go into recommending certain treatment options.
In this podcast, we’ll discuss the role of pathologists in cancer care.
A diagnosis of cancer can bring up many emotions and cause stress, anxiety, or depression for both patients and their families. In this podcast, we’ll discuss how seeing a Licensed Marriage and Family Therapist can help a person with cancer, how to find a marriage and family therapist, and what to expect from your visits.
In this podcast, Debra Haynes talks with Alejandro Muzio, George Donald, and Mariano Siles about meeting and working with a medical interpreter.
In this podcast, we’ll discuss meeting and working with a Child Life Specialist and some of the techniques they teach children to help them cope with their diagnosis and treatment.
Iris Cohen Fineberg, PhD, MSW, ACSW, OSW-C, and Penelope Damaskos, PhD, LCSW, OSW-C, discuss how social workers help patients get holistic care in partnership with the rest of the health care team.
This podcast explains what clinical trials are, and how they are conducted.
In this podcast, we discuss how to choose a doctor for your cancer care.
In this podcast, Dr. Richard Schilsky, an oncologist and the Chief Medical Officer of ASCO, provides an overview of ASCO’s second Top Five List in Oncology, issued in October 2013.